Literature DB >> 7988228

Mildly symptomatic pulmonary emboli associated with electrophysiologic procedures. Indications for anticoagulant use.

E Hockstad1, C C Gornick.   

Abstract

Symptomatic pulmonary emboli complicating electrophysiologic procedures are uncommon. Asymptomatic or mildly symptomatic embolic are likely much more common. This case report highlights the problem of extensive, but mildly symptomatic, pulmonary emboli occurring as a complication of electrophysiologic procedures, including catheter ablation. The role of anticoagulation during and following electrophysiologic procedures in preventing pulmonary emboli (which can have long-term sequelae) is unknown. Currently, there appears to be no consensus regarding the use of anticoagulants either during or following electrophysiologic procedures, including those involving catheter ablation. Based on the presumed frequency and potential long-term complications of pulmonary emboli, anticoagulation during electrophysiologic procedures should be recommended.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7988228     DOI: 10.1378/chest.106.6.1908

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation.

Authors:  Charles J Bruce; Paul A Friedman; Om Narayan; Thomas M Munger; Stephen C Hammill; Douglas L Packer; Samuel J Asirvatham
Journal:  J Interv Card Electrophysiol       Date:  2008-06-21       Impact factor: 1.900

2.  Pulmonary embolism as a complication of an electrophysiological study: a case report.

Authors:  Sahela Nasrin; Fathima Aaysha Cader; Mohammad Salahuddin; Tahera Nazrin; Jabed Iqbal; Masuma Jannat Shafi
Journal:  J Med Case Rep       Date:  2016-04-11

3.  Clinical Features of Acute Massive Pulmonary Embolism Complicated by Radiofrequency Ablation: An Observational Study.

Authors:  Yue-Chun Li; Jiafeng Lin; Lianpin Wu; Jia Li; Peng Chen; Xue-Qiang Guang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.